📣 Exciting news today about mRNA-1083, Moderna’s investigational combination vaccine against influenza and COVID-19. This vaccine has the potential to ease the burden on health systems and provide more convenient vaccination options against seasonal illnesses. A huge thank you to our dedicated teams for their hard work. Together, we're advancing healthcare solutions in our mission to deliver the greatest possible impact to people through #mRNA medicines.
We announced today that our Phase 3 trial of mRNA-1083, an investigational combination #vaccine against #influenza and #COVID19, has met its primary endpoints. mRNA-1083 comprises components of mRNA-1010, Moderna’s vaccine candidate for seasonal influenza, and mRNA-1283, Moderna’s next-generation COVID-19 vaccine candidate. Read more: https://lnkd.in/eiDqew4X
We need to innovate while also makes healthcare accessible and affordable by all! Great initiative! 👏🏼👏🏼👏🏼. Having timely feedback from people taking the vaccine with their feedback can help Pharma to quickly improve the quality of vaccines and refund risks. This is something we ZIPPYAR can help pharmaceutical companies theough our safe and compliant media streaming channel with a builtin platform for patients engagement. We are looking forward to delivering value to pharmaceutical companies and while making healthcare accessible and more affordable by all people.
Do these shots protect you from the illness and stop transmission?
I was part of Moderna vaccine Clinical trial from flu and Covid 19. I would like to Congrats Moderna on moving forward with the project. I have seen the high Quality work Moderna did during these mRna 1083 trials. Congrats# Moderna# Great work.
This is incredible. I can’t wait to see the publication and how the presentations turns out
🌟 Wonderful news, Stéphane! The development of mRNA-1083 is truly exciting and represents a significant step forward in streamlining protection against major seasonal illnesses. Huge congratulations to your teams for their dedication and innovation in advancing mRNA medicines. This could indeed make a remarkable difference in public health. Keep up the fantastic work! 🦢 Shine on 🫶
I would absolutely not get a combination shot. Prefer separate shots at separate times. I have enough of a reaction to each shot on its own.
Looking forward to reviewing the final results. It seems promising for next flu season.
Very exciting news. Excited to see the presentation/results. Great work.
Global Biopharma Leader | Boosting Growth with AI | Quiet extrovert
1moNot for me. My second Moderna « COVID » shot sent me to bed for one week with V-shape fever, headaches and muscle cramps and I developed IBD right after. Never again.